Home
Home

Mesoblast

Pluristem Standardizes Stem Cell Therapy, Opening Door To The Future Of Medicine

Pluristem Standardizes Stem Cell Therapy, Opening Door To The Future Of Medicine
Seeking Alpha

The Next Big Growth Sector In Health Care: Stem Cell Therapy

The Next Big Growth Sector In Health Care: Stem Cell Therapy
Seeking Alpha

Biotech 2012 Kickoff Party: Investor Preview

Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com

FACTBOX-Stem cell advances focus on heart, inflammation

FACTBOX-Stem cell advances focus on heart, inflammation
Reuters

Athersys Shares Poised To Move Higher

Athersys Shares Poised To Move Higher
Seeking Alpha

Teva Pharma Is ‘Ideal Partner,’ Mesoblast CEO Itescu Says

Teva Pharma Is ‘Ideal Partner,’ Mesoblast CEO Itescu Says
Bloomberg

News

Time to Buy Into Stem Cells?
Motley Fool

News

Cephalon Stem Cell Deal Catches Analysts Off-Guard
Seeking Alpha

News

Cephalon Buys Mesoblast Stake, Drug Rights in Potential $2 Billion Deal
Bloomberg

News

Stem Cell Developer Mesoblast Seeks Bone Marrow Therapy by 2012
Bloomberg
»